CD13 inhibitor ubenimex was employed to treat human lung adenocarcinoma cell line A549 and human breast cancer cell line MDA-MB-231 cells combined with GEM, pemetrexed (Pem) and paclitaxel (PTX). Here, ANPEP is linked to breast carcinoma.